nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyprylon—CYP2D6—Parkinson's disease	0.87	1	CbGaD
Methyprylon—Ethosuximide—CYP2E1—Parkinson's disease	0.00761	1	CrCbGaD
Methyprylon—GABRA1—hindbrain—Parkinson's disease	0.00378	0.0806	CbGeAlD
Methyprylon—GABRG2—forebrain—Parkinson's disease	0.00237	0.0505	CbGeAlD
Methyprylon—GABRB3—GABA receptor activation—KCNJ4—Parkinson's disease	0.00223	0.0296	CbGpPWpGaD
Methyprylon—GABRG2—GABA receptor activation—KCNJ4—Parkinson's disease	0.00219	0.0291	CbGpPWpGaD
Methyprylon—GABRA1—brainstem—Parkinson's disease	0.00217	0.0462	CbGeAlD
Methyprylon—GABRA1—forebrain—Parkinson's disease	0.00209	0.0446	CbGeAlD
Methyprylon—GABRA1—GABA receptor activation—KCNJ4—Parkinson's disease	0.00191	0.0254	CbGpPWpGaD
Methyprylon—GABRB3—forebrain—Parkinson's disease	0.00182	0.0388	CbGeAlD
Methyprylon—GABRG2—medulla oblongata—Parkinson's disease	0.00171	0.0365	CbGeAlD
Methyprylon—CYP2D6—hindbrain—Parkinson's disease	0.00166	0.0353	CbGeAlD
Methyprylon—GABRG2—midbrain—Parkinson's disease	0.00156	0.0333	CbGeAlD
Methyprylon—GABRG2—spinal cord—Parkinson's disease	0.00153	0.0325	CbGeAlD
Methyprylon—GABRA1—medulla oblongata—Parkinson's disease	0.00151	0.0322	CbGeAlD
Methyprylon—GABRA1—midbrain—Parkinson's disease	0.00138	0.0294	CbGeAlD
Methyprylon—GABRG2—head—Parkinson's disease	0.00136	0.0289	CbGeAlD
Methyprylon—GABRA1—spinal cord—Parkinson's disease	0.00135	0.0287	CbGeAlD
Methyprylon—GABRB3—medulla oblongata—Parkinson's disease	0.00131	0.028	CbGeAlD
Methyprylon—GABRG2—nervous system—Parkinson's disease	0.00129	0.0274	CbGeAlD
Methyprylon—GABRG2—central nervous system—Parkinson's disease	0.00124	0.0264	CbGeAlD
Methyprylon—GABRG2—cerebellum—Parkinson's disease	0.00121	0.0258	CbGeAlD
Methyprylon—GABRB3—midbrain—Parkinson's disease	0.0012	0.0256	CbGeAlD
Methyprylon—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.0012	0.0159	CbGpPWpGaD
Methyprylon—GABRA1—head—Parkinson's disease	0.0012	0.0255	CbGeAlD
Methyprylon—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00119	0.0158	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—DOCK3—Parkinson's disease	0.00118	0.0157	CbGpPWpGaD
Methyprylon—GABRB3—spinal cord—Parkinson's disease	0.00117	0.025	CbGeAlD
Methyprylon—GABRA1—nervous system—Parkinson's disease	0.00114	0.0242	CbGeAlD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00111	0.0148	CbGpPWpGaD
Methyprylon—GABRA1—central nervous system—Parkinson's disease	0.00109	0.0233	CbGeAlD
Methyprylon—GABRA1—cerebellum—Parkinson's disease	0.00107	0.0228	CbGeAlD
Methyprylon—GABRB3—head—Parkinson's disease	0.00104	0.0222	CbGeAlD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00102	0.0136	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00101	0.0134	CbGpPWpGaD
Methyprylon—GABRB3—nervous system—Parkinson's disease	0.000988	0.021	CbGeAlD
Methyprylon—GABRG2—brain—Parkinson's disease	0.000983	0.0209	CbGeAlD
Methyprylon—GABRB3—Ion channel transport—ATP1A3—Parkinson's disease	0.000955	0.0127	CbGpPWpGaD
Methyprylon—GABRB3—Ion channel transport—TRPM7—Parkinson's disease	0.000955	0.0127	CbGpPWpGaD
Methyprylon—GABRB3—central nervous system—Parkinson's disease	0.000951	0.0203	CbGeAlD
Methyprylon—CYP2D6—brainstem—Parkinson's disease	0.00095	0.0202	CbGeAlD
Methyprylon—GABRG2—Ion channel transport—TRPM7—Parkinson's disease	0.000938	0.0125	CbGpPWpGaD
Methyprylon—GABRG2—Ion channel transport—ATP1A3—Parkinson's disease	0.000938	0.0125	CbGpPWpGaD
Methyprylon—GABRB3—cerebellum—Parkinson's disease	0.000929	0.0198	CbGeAlD
Methyprylon—CYP2D6—forebrain—Parkinson's disease	0.000917	0.0195	CbGeAlD
Methyprylon—GABRB3—Neuronal System—HCN3—Parkinson's disease	0.000915	0.0122	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—HCN3—Parkinson's disease	0.000899	0.012	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.000884	0.0118	CbGpPWpGaD
Methyprylon—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000882	0.0117	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.000879	0.0117	CbGpPWpGaD
Methyprylon—GABRA1—brain—Parkinson's disease	0.000868	0.0185	CbGeAlD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.000868	0.0116	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—DLG1—Parkinson's disease	0.000864	0.0115	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000845	0.0112	CbGpPWpGaD
Methyprylon—GABRA1—Ion channel transport—ATP1A3—Parkinson's disease	0.00082	0.0109	CbGpPWpGaD
Methyprylon—GABRA1—Ion channel transport—TRPM7—Parkinson's disease	0.00082	0.0109	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—HCN3—Parkinson's disease	0.000786	0.0105	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00077	0.0102	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.000759	0.0101	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000756	0.0101	CbGpPWpGaD
Methyprylon—GABRB3—brain—Parkinson's disease	0.000755	0.0161	CbGeAlD
Methyprylon—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000738	0.00981	CbGpPWpGaD
Methyprylon—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000709	0.00944	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.000692	0.0092	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.000679	0.00904	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000664	0.00884	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000661	0.00879	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000652	0.00868	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.000594	0.0079	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—KCNJ4—Parkinson's disease	0.00059	0.00785	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.000588	0.00783	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—KCNJ4—Parkinson's disease	0.000579	0.00771	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.000577	0.00769	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00057	0.00759	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000527	0.00702	CbGpPWpGaD
Methyprylon—CYP2D6—head—Parkinson's disease	0.000525	0.0112	CbGeAlD
Methyprylon—GABRB3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00052	0.00692	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000511	0.00679	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—DLG1—Parkinson's disease	0.000509	0.00678	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—KCNJ4—Parkinson's disease	0.000506	0.00674	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.000505	0.00672	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—MAPT—Parkinson's disease	0.0005	0.00666	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—DLG1—Parkinson's disease	0.0005	0.00665	CbGpPWpGaD
Methyprylon—CYP2D6—nervous system—Parkinson's disease	0.000498	0.0106	CbGeAlD
Methyprylon—CYP2D6—central nervous system—Parkinson's disease	0.000479	0.0102	CbGeAlD
Methyprylon—CYP2D6—cerebellum—Parkinson's disease	0.000468	0.00998	CbGeAlD
Methyprylon—GABRB3—Orphan transporters—CYCS—Parkinson's disease	0.000455	0.00605	CbGpPWpGaD
Methyprylon—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000451	0.006	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000451	0.006	CbGpPWpGaD
Methyprylon—GABRG2—Orphan transporters—CYCS—Parkinson's disease	0.000447	0.00594	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000446	0.00594	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000443	0.00589	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000442	0.00588	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—DLG1—Parkinson's disease	0.000437	0.00582	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000434	0.00578	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000428	0.0057	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00042	0.0056	CbGpPWpGaD
Methyprylon—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00042	0.00559	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—GRIK1—Parkinson's disease	0.000398	0.0053	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—GRIK1—Parkinson's disease	0.000391	0.00521	CbGpPWpGaD
Methyprylon—GABRA1—Orphan transporters—CYCS—Parkinson's disease	0.00039	0.0052	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000388	0.00516	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000387	0.00515	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000381	0.00507	CbGpPWpGaD
Methyprylon—CYP2D6—brain—Parkinson's disease	0.00038	0.0081	CbGeAlD
Methyprylon—GABRA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000379	0.00505	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000379	0.00504	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000372	0.00495	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—GRIN2B—Parkinson's disease	0.000371	0.00493	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000368	0.00489	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000365	0.00486	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000355	0.00472	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—GRIK1—Parkinson's disease	0.000342	0.00455	CbGpPWpGaD
Methyprylon—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000342	0.00455	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000342	0.00455	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000339	0.00451	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—GRIK2—Parkinson's disease	0.000339	0.00451	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000336	0.00448	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000333	0.00443	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000333	0.00443	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—GRIK2—Parkinson's disease	0.000333	0.00443	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000332	0.00442	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000332	0.00442	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—SLC18A2—Parkinson's disease	0.000328	0.00437	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000326	0.00434	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000326	0.00434	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000325	0.00433	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—SLC18A2—Parkinson's disease	0.000322	0.00429	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000311	0.00413	CbGpPWpGaD
Methyprylon—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000306	0.00408	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000305	0.00406	CbGpPWpGaD
Methyprylon—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000302	0.00402	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—BDNF—Parkinson's disease	0.000297	0.00396	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000294	0.00391	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000291	0.00388	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000291	0.00387	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.000291	0.00387	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000286	0.00381	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000285	0.0038	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000285	0.0038	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000285	0.00379	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000282	0.00375	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000281	0.00374	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00028	0.00372	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000276	0.00367	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000267	0.00355	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—NGF—Parkinson's disease	0.000264	0.00351	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—CHRNA4—Parkinson's disease	0.00026	0.00346	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—CHRNA4—Parkinson's disease	0.000255	0.00339	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00025	0.00333	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000248	0.0033	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000248	0.0033	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000245	0.00325	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000241	0.00321	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000239	0.00319	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000239	0.00318	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—HSPA8—Parkinson's disease	0.000238	0.00317	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000237	0.00315	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000234	0.00312	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000234	0.00311	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000233	0.0031	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000223	0.00297	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000223	0.00297	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000219	0.00292	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000218	0.0029	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000218	0.0029	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000215	0.00286	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000215	0.00286	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000214	0.00285	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000213	0.00283	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000211	0.00281	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000205	0.00273	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000204	0.00272	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000204	0.00272	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000203	0.00271	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000202	0.00269	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000194	0.00258	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000192	0.00255	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000187	0.00249	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000185	0.00246	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000183	0.00243	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000182	0.00242	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—COMT—Parkinson's disease	0.00018	0.00239	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000178	0.00237	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000176	0.00235	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000173	0.00231	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000162	0.00216	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000159	0.00212	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000157	0.00209	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000156	0.00207	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000151	0.00201	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000149	0.00198	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000139	0.00185	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000137	0.00182	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000132	0.00176	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00013	0.00173	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00012	0.0016	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00012	0.00159	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000116	0.00154	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000114	0.00151	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000111	0.00148	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000109	0.00145	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000109	0.00145	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000109	0.00145	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.00144	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000108	0.00143	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000107	0.00143	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	9.99e-05	0.00133	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.93e-05	0.00132	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.86e-05	0.00131	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.65e-05	0.00128	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.53e-05	0.00127	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.48e-05	0.00126	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.27e-05	0.00123	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.1e-05	0.00121	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.7e-05	0.00116	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.29e-05	0.0011	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.95e-05	0.00106	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.09e-05	0.000943	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ND3—Parkinson's disease	7.09e-05	0.000943	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.02e-05	0.000935	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.66e-05	0.000887	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—OMD—Parkinson's disease	6.66e-05	0.000887	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.32e-05	0.000841	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.03e-05	0.000802	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GBA—Parkinson's disease	5.37e-05	0.000715	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—DBH—Parkinson's disease	5.37e-05	0.000715	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.37e-05	0.000715	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—DDC—Parkinson's disease	3.94e-05	0.000525	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.72e-05	0.000495	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.35e-05	0.000446	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.32e-05	0.000442	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.42e-05	0.000322	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.26e-05	0.0003	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.23e-05	0.000297	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TH—Parkinson's disease	2.2e-05	0.000292	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.11e-05	0.000281	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—COMT—Parkinson's disease	1.87e-05	0.000249	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.86e-05	0.000248	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.86e-05	0.000247	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.83e-05	0.000244	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.76e-05	0.000234	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.71e-05	0.000227	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.64e-05	0.000218	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.51e-05	0.000201	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—APOE—Parkinson's disease	1.41e-05	0.000187	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—INS—Parkinson's disease	1.2e-05	0.00016	CbGpPWpGaD
